US: +1 646-781-8004 | Europe:+44-203-868-8738 | APAC:+91-744-778-0008

Blood Screening Market

Release date:

Jan-2021

Region:

global

Research Code:MRHC -104470

Sku:MRHC -104470

Blood Screening Market by Product (Reagents and Kits, Instruments, Software), Technology (NAAT [Real-time PCR], ELISA [CLIA, FIA, CI], Rapid Tests, Western Blotting, NGS), and End User (Blood Banks, Hospitals, Laboratories)-Global Forecast to 2027

  • Report ID: MRHC -104470
  • Pages: 200
  • Jan-2021
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours
COVID-19

This report provides pre & post COVID-19 market estimates.

The blood screening market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach $3.56 billion by 2027. Blood screening is one of the most ideal and preferred tests for diagnosing various infectious diseases. Blood screening enables physicians to diagnose diseases effectively, which helps in administering suitable treatments and monitoring the patient to avoid the spread of the disease.

Factors such as the rise in blood donations and blood transfusion-related screenings, increasing prevalence of infectious diseases, growing geriatric population, and increasing awareness about transfusion-transmitted diseases are driving the growth of this market. Untapped emerging markets such as India and China and advancements in technology hold great opportunities for this market to grow during the forecast period.

However, the lack of legislation, regulation, and policies regarding blood transfusion-related activities in some countries and the development of alternative technologies replacing blood screening are expected to hinder the growth of this market to a certain extent.

Blood Screening Market

                                                          Click here to: Get Free Sample Pages of this Report

The Impact of COVID-19 on the Blood Screening Market

The COVID-19 pandemic has influenced the blood screening market both positively and negatively. The outbreak of COVID-19 led to the immediate development of several serological tests to detect COVID-19 antibodies by many companies. For instance, the U.S. FDA granted Emergency Use Authorization (EUA) to about 50 serological tests to detect COVID-19 antibodies. These tests are intended to study the seroprevalence of the virus in a given population. Moreover, there has been a drastic increase in the number of hospitalizations, which is expected to increase the demand for donated blood or its components and positively influence the blood screening market.

In August 2020, the U.S. FDA issued an emergency use authorization (EUA) for the convalescent plasma treatment for COVID-19 in hospitalized patients. The patients who survived the COVID-19 infection have high levels of IgG antibodies against the virus in their plasma. Hence their plasma can be extracted and used to treat other COVID-19 patients. The FDA commissioner encouraged COVID-19 survivors to donate plasma since April 2020. As of August 2020, 40,000 patients in the U.S. have received plasma treatment for COVID-19. The demand for plasma treatment is rising along with the number of plasma donations worldwide. All the donated plasma must be screened for various infectious diseases and blood typing tests. Therefore, this factor is expected to positively impact the blood screening market.

However, the number of blood donations and blood transfusion-related screenings has taken a hit due to the lockdown and restrictions imposed during the pandemic. The number of blood donations reduced significantly due to the lockdowns and the fear of getting infected, which in turn reduced the blood transfusion-related screenings. However, the number of blood donations has increased since lockdown restrictions have been relaxed. The American Red Cross also began testing all blood, platelet, and plasma donations for COVID-19 antibodies to provide the donor insights into whether they have been exposed to the coronavirus.

Therefore, even though blood donations and transfusion-related screenings might have taken a hit during the peak months of the pandemic, the overall impact of COVID-19 is expected to contribute positively toward the growth of the blood screening market.

Key Findings of the Blood Screening Market Study:

The Reagents & Kits Segment to Dominate the Market

By product, the reagents & kits segment is projected to command the largest share of the blood screening market in 2020. Reagents being a recurrent expense, are extensively used for immunoassays and molecular tests. Factors such as increasing blood donations and transfusion-related screenings and the increasing prevalence of infectious diseases are driving the growth of this segment. Moreover, due to the outbreak of COVID-19, there has been an increase in serological testing, which has also contributed to the growth of this segment.

The Nucleic Acid Amplification Segment to Dominate the Market

By technology, the nucleic acid amplification segment is projected to command the largest share of the blood screening market in 2020. The largest share is attributed to the superior benefits of the technology, such as high sensitivity and specificity for early detection. Moreover, the widespread adoption of this technology in blood banks, hospitals, and clinical laboratories also contributes to its largest share. Additionally, the high adoption of this technology in emerging markets and developing countries provides great opportunities for the growth of this segment. However, requirements such as skilled labor and high-cost initial infrastructure are expected to pose challenges for the growth of this segment.

The Blood Banks Segment to Dominate the Market

By End User, the blood banks segment is projected to command the largest share of the blood screening market. Laboratory screening of donated blood and blood products for infectious diseases is a key safety measure to protect patients and to prevent the spread of serious infectious diseases. Factors such as increasing blood donations and transfusion-related screenings, growing awareness about transfusion-transmitted infections, and the rising occurrence of infectious diseases are driving the growth of this segment.

North America: The Largest Regional Market

In 2020, North America is expected to dominate the blood screening market. North America’s largest share is primarily attributed to the increasing blood transfusion-related screenings, growing prevalence of infectious diseases, rising geriatric population, need for early disease diagnosis and monitoring, increasing healthcare expenditure, and the growing adoption of advanced blood screening technologies in the region.

Key Players

The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments by leading market players in the industry over the past four years (2017–2020). The key players profiled in the blood screening market are Abbott Laboratories (U.S.), OriGene Technologies, Inc. (U.S.), BioAim Scientific Inc. (Canada), bioMérieux, Inc. (France), Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immuno-Biological Laboratories Co., Ltd. (Japan), Biovision, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Boster Biological Technology (U.S.), Cusabio Technology LLC (U.S.), Danaher Corporation (U.S.), Demeditec Diagnostics GmbH (Germany), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.

Scope of the Report:

Blood Screening Market, by Product

  • Reagents & Kits
    • NAT Kits & Reagents
    • ELISA Kits & Reagents
    • Other Kits & Reagents
  • Instruments
  • Software & Services

Blood Screening Market, by Technology

  • Nucleic Acid Amplification
    • Transcription Mediated Amplification (TMA)
    • Real-time PCR
  • ELISA
    • Chemiluminescence Immunoassay (CLIA)
    • Fluorescence Immunoassay (FIA)
    • Colorimetric Immunoassay (CI)
  • Rapid Tests
  • Western Blotting
  • Next-generation Sequencing (NGS)

Blood Screening Market, by End User

  • Blood Banks
  • Hospitals
  • Clinical Laboratories

Blood Screening Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key Questions Answered in the Report:

What is the scope of the blood screening market report?

The blood screening market report covers the market size & forecasts for various product, technology, and end-user segments, across geographies. The blood screening market study in this report includes the value analysis of various segments and subsegments of the blood screening market at the regional and country levels.

What is the revenue generated from blood screening products across the globe? At what rate is their demand expected to grow for the next 5–7 years?

The blood screening market is projected to reach $3.56 billion by 2027, at a CAGR of 6.9% during the forecast period, 2020–2027.

What are the various technologies used for blood screening, and which technology holds the major market share?

The various technologies used for blood screening are nucleic acid amplification, ELISA, rapid tests, western blotting, and next-generation sequencing. In 2020, the nucleic acid amplification segment is estimated to account for the largest share of the blood screening market.

What are the various product categories for blood screening, and which category holds the largest market share?

Various product categories include reagents & kits, instruments, and software & services. In 2020, the reagents & kits segment is estimated to account for the largest share of the blood screening market.

Which end-user segment is projected to create more traction in the global blood screening market?

In 2020, the blood banks segment is estimated to account for the largest share of the blood screening market. The blood banks segment is also projected to register the highest CAGR during the forecast period owing to factors such as increasing blood donations and transfusion-related screenings, the rising prevalence of infectious diseases, growing awareness about transfusion-transmitted diseases, and increasing plasma donations for COVID-19 treatment.

What are the key factors supporting the growth of this market? What are the major opportunities for the market players in the global blood screening market?

Increasing blood donations and blood transfusion-related screenings, the prevalence of infectious diseases, the rising geriatric population, and growing awareness about transfusion-transmitted diseases are the key factors supporting the growth of this market. Untapped markets in developing and underdeveloped countries and advancements in technology are some of the factors that hold significant growth opportunities for players operating in this market.

Who are the major players operating in the global blood screening market?

The key players operating in the blood screening market are Abbott Laboratories (U.S.), OriGene Technologies, Inc. (U.S.), BioAim Scientific Inc. (Canada), bioMérieux, Inc. (France), Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immuno-Biological Laboratories Co., Ltd. (Japan), Biovision, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Boster Biological Technology (U.S.), Cusabio Technology LLC (U.S.), Danaher Corporation (U.S.), Demeditec Diagnostics GmbH (Germany), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.

Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the global blood screening market?

Emerging economies like China, India, Brazil, etc. are projected to offer significant growth opportunities for the vendors in this market due to increasing blood transfusion-related screenings, rapid urbanization, rising prevalence of infectious diseases, rising geriatric populations, increasing investments in infrastructure improvement by healthcare providers, need for early disease diagnosis, government initiatives to promote blood donations, and increasing awareness about transfusion-transmitted diseases.

1. Introduction
      1.1. Market Definition
      1.2. Market Ecosystem
      1.3. Currency
      1.4. Key Stakeholders

2. Research Methodology
      2.1. Research Process
      2.2. Data Collection & Validation
              2.2.1. Secondary Research
              2.2.2. Primary Research
      2.3. Market Assessment
              2.3.1. Market Size Estimation
                         2.3.1.1. Bottom-up Approach
                         2.3.1.2. Top-down Approach
                         2.3.1.3. Growth forecast
              2.3.2. Market Share Analysis
      2.4. Assumptions for this Study
      2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
      4.1. Introduction
      4.2. Drivers
              4.2.1. Increasing Number of Blood Donations and Transfusion-related Screenings
              4.2.2. Growing Prevalence of Infectious Diseases and the Need for Early Diagnosis
              4.2.3. Increasing Government and Non-government Initiatives
      4.3. Restraints
              4.3.1. Lack of Legislation, Regulations, and Policies
              4.3.2. Development of Alternative Technologies
      4.4. Opportunities
              4.4.1. Emerging Markets in Developing and Underdeveloped Countries
              4.4.2. Adoption of New Technologies & Rapid Technological Advancements
      4.5. Challenges
              4.5.1. Increasing Competition
      4.6. COVID-19 Impact Assessment 

5. Global Blood Screening Market, by Product
      5.1. Introduction
      5.2. Reagents & Kits
              5.2.1. NAT Reagents & Kits
              5.2.2. ELISA Reagents & Kits
              5.2.3. Other Reagents & Kits
      5.3. Instruments
      5.4. Software & Services

6. Global Blood Screening Market, by Technology
      6.1. Introduction
      6.2. Nucleic Acid Amplification
              6.2.1. Transcription Mediated Amplification (TMA)
              6.2.2. Real-time PCR (RT-PCR)
      6.3. Enzyme-linked Immunosorbent Assay (ELISA)
              6.3.1. Chemiluminescent Immunoassay
              6.3.2. Fluorescence Immunoassays (FIA)
              6.3.3. Colorimetric Immunoassays (CI)
      6.4. Rapid Tests
      6.5. Western Blotting
      6.6. Next-generation Sequencing (NGS)

7. Global Blood Screening Market, by End User
      7.1. Introduction
      7.2. Blood Banks
      7.3. Hospitals
      7.4. Clinical Laboratories

8. Global Blood Screening Market, by Geography
      8.1. Introduction
      8.2. North America
              8.2.1. U.S.
              8.2.2. Canada
      8.3. Europe
              8.3.1. Germany
              8.3.2. France
              8.3.3. U.K.
              8.3.4. Italy
              8.3.5. Spain
              8.3.6. Rest of Europe (RoE)
      8.4. Asia-Pacific
              8.4.1. China
              8.4.2. Japan
              8.4.3. India
              8.4.4. Rest of Asia-Pacific (RoAPAC)
      8.5. Latin America
      8.6. Middle East & Africa

9. Competitive Landscape
      9.1. Introduction
      9.2. Key Growth Strategies
      9.3. Competitive Benchmarking
      9.4. Market Share Analysis (2019)
              9.4.1. Becton, Dickinson and Company
              9.4.2. Abbott Laboratories
              9.4.3. F. Hoffmann-La Roche Ltd

10. Company Profiles
        10.1. Abbott Laboratories
                  10.1.1. Business Overview
                  10.1.2. Financial Overview
                  10.1.3. Product Portfolio
                  10.1.4. Strategic Developments
                               10.1.4.1. New Product Launches & Approvals
                               10.1.4.2. Partnerships
        10.2. bioMerieux, Inc.
                  10.2.1. Business Overview
                  10.2.2. Financial Overview
                  10.2.3. Product Portfolio
                  10.2.4. Strategic Developments
                               10.2.4.1. Approvals
                               10.2.4.2. Acquisitions
        10.3. Bio-Rad Laboratories, Inc.
                  10.3.1. Business Overview
                  10.3.2. Financial Overview
                  10.3.3. Product Portfolio
                  10.3.4. Strategic Developments
                               10.3.4.1. New Product Launches & Approvals
        10.4. Grifols, S.A.
                  10.4.1. Business Overview
                  10.4.2. Financial Overview
                  10.4.3. Product Portfolio
                  10.4.4. Strategic Developments
                               10.4.4.1. Approvals
                               10.4.4.2. Acquisitions
                               10.4.4.3. Agreements
        10.5. Becton, Dickinson and Company
                  10.5.1. Business Overview
                  10.5.2. Financial Overview
                  10.5.3. Product Portfolio
                  10.5.4. Strategic Developments
                               10.5.4.1. New Product Launches
                               10.5.4.2. Agreements
        10.6. F. Hoffmann-La Roche Ltd.
                  10.6.1. Business Overview
                  10.6.2. Financial Overview
                  10.6.3. Product Portfolio
                  10.6.4. Strategic Developments
                               10.6.4.1. New Product Launches & Approvals
        10.7. Boster Biological Technology
                  10.7.1. Business Overview
                  10.7.2. Product Portfolio
                  10.7.3. Strategic Developments
                               10.7.3.1. Partnerships
        10.8. Cusabio Technology LLC
                  10.8.1. Business Overview
                  10.8.2. Product Portfolio
        10.9. Danaher Corporation
                  10.9.1. Business Overview
                  10.9.2. Financial Overview
                  10.9.3. Product Portfolio
                  10.9.4. Strategic Developments
                               10.9.4.1. New Product Launches & Approvals
                               10.9.4.2. Acquisitions
                               10.9.4.3. Collaborations
        10.10. Demeditec Diagnostics GmbH
                    10.10.1. Business Overview
                    10.10.2. Product Portfolio
                    10.10.3. Strategic Developments
                                  10.10.3.1. New Product Launches

11. Appendix
        11.1. Questionnaire
        11.2. Available Customization

List of Tables :-

Table 1 Global Blood Screening Market Drivers: Impact Analysis (2020–2027)
Table 2 Estimated Units of Donated Blood Collected Per Year
Table 3 List of Donor Blood Screening Tests
Table 4 Global Blood Screening Market Restraints: Impact Analysis (2020–2027)
Table 5 Percentage of Countries Lacking National Blood Policy per Region
Table 6 COVID-19 Confirmed Cases and Deaths Worldwide (as of 21st December 2020)
Table 7 Recent Serological Tests Launched for COVID-19
Table 8 Global Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 9 Global Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 10 Global Blood Screening Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 11 Recent Approvals for Nat Reagents & Kits
Table 12 Key Companies Offering Blood Screening Nat Reagents & Kits
Table 13 Global NAT Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 14 Recent Launches and Approvals for ELISA Reagents & Kits
Table 15 Key Companies Offering Blood Screening ELISA Reagents & Kits
Table 16 Global ELISA Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 17 Key Companies Offering Other Reagents & Kits
Table 18 Global Other Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 19 Recent Instrument Launches & Approvals
Table 20 Key Companies Offering Blood Screening Instruments
Table 21 Global Blood Screening Instruments Market Size, by Country/Region, 2018–2027 (USD Million)
Table 22 Key Companies Offering Blood Screening Software & Services
Table 23 Global Blood Screening Software & Services Market Size, by Country/Region, 2018–2027 (USD Million)
Table 24 Global Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 25 Global Nucleic Acid Amplification-based Blood Screening Market Size, by Type, 2018–2027 (USD Million)
Table 26 Global Nucleic Acid Amplification-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 27 Global TMA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 28 Key Companies Offering Real-time PCR-based Blood Screening Products
Table 29 Global Real-time PCR-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 30 Global ELISA-based Blood Screening Market Size, by Type, 2018–2027 (USD Million)
Table 31 Global ELISA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 32 Key Companies Offering CLIA-based Products
Table 33 Global CLIA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 34 Key Companies Offering FIA-based Products
Table 35 Global FIA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 36 Key Companies Offering CI-based Products
Table 37 Global CI-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 38 Key Companies Offering Rapid Test-based Products
Table 39 Global Rapid Test-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 40 Key Companies Offering Western Blotting-based Products
Table 41 Global Western Blotting-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 42 Global Next-generation Sequencing-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 43 Global Blood Screening Market Size, by End User, 2020–2027 (USD Million)
Table 44 Global Blood Screening Market Size for Blood Banks, by Country/Region, 2020–2027 (USD Million)
Table 45 Global Blood Screening Market Size for Hospitals, by Country/Region, 2020–2027 (USD Million)
Table 46 Global Blood Screening Market Size for Clinical Laboratories, by Country/Region, 2020–2027 (USD Million)
Table 47 Global Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 48 North America: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 49 North America: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 50 North America: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 51 North America: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 52 North America: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 53 North America: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 54 North America: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 55 Blood Screening Tests Recommended by Centers for Disease Control & Prevention
Table 56 U.S.: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 57 U.S.: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 58 U.S.: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 59 U.S.: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 60 U.S.: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 61 U.S.: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 62 Canada: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 63 Canada: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 64 Canada: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 65 Canada: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 66 Canada: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 67 Canada: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 68 Europe: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 69 Europe: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 70 Europe: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 71 Europe: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 72 Europe: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 73 Europe: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 74 Europe: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 75 Germany: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 76 Germany: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 77 Germany: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 78 Germany: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 79 Germany: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 80 Germany: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 81 France: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 82 France: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 83 France: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 84 France: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 85 France: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 86 France: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 87 U.K.: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 88 U.K.: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 89 U.K.: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 90 U.K.: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 91 U.K.: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 92 U.K.: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 93 Italy: Cancer Prevalence 2020
Table 94 Italy: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 95 Italy: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 96 Italy: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 97 Italy: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 98 Italy: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 99 Italy: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 100 Spain: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 101 Spain: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 102 Spain: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 103 Spain: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 104 Spain: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 105 Spain: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 106 RoE: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 107 RoE: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 108 RoE: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 109 RoE: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 110 RoE: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 111 RoE: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 112 Asia-Pacific: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 113 Asia-Pacific: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 114 Asia-Pacific: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 115 Asia-Pacific: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 116 Asia-Pacific: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 117 Asia-Pacific: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 118 Asia-Pacific: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 119 China: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 120 China: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 121 China: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 122 China: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 123 China: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 124 China: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 125 Japan: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 126 Japan: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 127 Japan: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 128 Japan: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 129 Japan: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 130 Japan: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 131 India: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 132 India: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 133 India: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 134 India: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 135 India: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 136 India: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 137 Rest of Asia-Pacific: Number of Infectious Disease Cases in Major Countries
Table 138 RoAPAC: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 13  RoAPAC: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 140 RoAPAC: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 141 RoAPAC: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 142 RoAPAC: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 143 RoAPAC: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 144 Latin America: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 145 Latin America: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 146 Latin America: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 147 Latin America: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 148 Latin America: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 149 Latin America: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 150 Middle East & Africa: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 151 Middle East & Africa: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 152 Middle East & Africa: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 153 Middle East & Africa: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 154 Middle East & Africa: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 155 Middle East & Africa: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 156 Recent Developments, by Company, 2017–2020

List of Figures :-

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Blood Screening Market Size, by Product, 2020 Vs. 2027 (USD Million)
Figure 8 Global Blood Screening Market Size, by Technology, 2020 Vs. 2027 (USD Million)
Figure 9 Blood Banks Segment Expected to Dominate the Global Blood Screening Market, by End User, (2020–2027)
Figure 10 Blood Screening Market, by Region
Figure 11 Market Dynamics
Figure 12 Global Blood Screening Market Size, by Product, 2020–2027 (USD Million)
Figure 13 Global Blood Screening Market Size, by Technology, 2020–2027 (USD Million)
Figure 14 Global Blood Screening Market Size, by End User, 2020–2027 (USD Million)
Figure 15 Global Blood Screening Market Size, by Geography, 2020–2027 (USD Million)
Figure 16 North America: Blood Screening Market Snapshot
Figure 17 Europe: Blood Screening Market Snapshot
Figure 18 Asia-Pacific: Blood Screening Market Snapshot
Figure 19 Middle East & Africa: Road Fatalities per 100,000 Population per Year
Figure 20 Key Growth Strategies Adopted by Leading Players, 2017–2020
Figure 21 Blood Screening: Competitive Benchmarking
Figure 22 Blood Screening: Competitive Benchmarking by Geography
Figure 23 Market Share Analysis: Blood Screening Industry, 2019
Figure 24 Abbott Laboratories: Financial Overview (2019)
Figure 25 bioMerieux, Inc.: Financial Overview (2019)
Figure 26 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
Figure 27 Grifols, S.A.: Financial Overview (2019)
Figure 28 Becton, Dickinson and Company: Financial Overview (2019)
Figure 29 F. Hoffmann-La Roche Ltd: Financial Overview (2019)
Figure 30 Danaher Corporation: Financial Overview (2019)

 
Name can only consist of alphabets.
Please provide your full name.
 
Please provide valid email address.
Please provide your email address.
 
Please provide your job title.
 
Please provide your company name.
 
Please provide your company name.
 
Please provide valid phone number.
Please provide your phone number.
 
Please enter minimum 10 characters.
 
Please enter Captcha.
Please enter valid Captcha.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Related Research

The blood screening market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach $3.56 billion by 2027. Blood screening is one of the most ideal and preferred tests for diagnosing various infectious diseases. Blood screening enables physicians to diagnose diseases effectively, which helps in administering suitable treatments and monitoring the patient to avoid the spread of the disease.

Factors such as the rise in blood donations and blood transfusion-related screenings, increasing prevalence of infectious diseases, growing geriatric population, and increasing awareness about transfusion-transmitted diseases are driving the growth of this market. Untapped emerging markets such as India and China and advancements in technology hold great opportunities for this market to grow during the forecast period.

However, the lack of legislation, regulation, and policies regarding blood transfusion-related activities in some countries and the development of alternative technologies replacing blood screening are expected to hinder the growth of this market to a certain extent.

Blood Screening Market

                                                          Click here to: Get Free Sample Pages of this Report

The Impact of COVID-19 on the Blood Screening Market

The COVID-19 pandemic has influenced the blood screening market both positively and negatively. The outbreak of COVID-19 led to the immediate development of several serological tests to detect COVID-19 antibodies by many companies. For instance, the U.S. FDA granted Emergency Use Authorization (EUA) to about 50 serological tests to detect COVID-19 antibodies. These tests are intended to study the seroprevalence of the virus in a given population. Moreover, there has been a drastic increase in the number of hospitalizations, which is expected to increase the demand for donated blood or its components and positively influence the blood screening market.

In August 2020, the U.S. FDA issued an emergency use authorization (EUA) for the convalescent plasma treatment for COVID-19 in hospitalized patients. The patients who survived the COVID-19 infection have high levels of IgG antibodies against the virus in their plasma. Hence their plasma can be extracted and used to treat other COVID-19 patients. The FDA commissioner encouraged COVID-19 survivors to donate plasma since April 2020. As of August 2020, 40,000 patients in the U.S. have received plasma treatment for COVID-19. The demand for plasma treatment is rising along with the number of plasma donations worldwide. All the donated plasma must be screened for various infectious diseases and blood typing tests. Therefore, this factor is expected to positively impact the blood screening market.

However, the number of blood donations and blood transfusion-related screenings has taken a hit due to the lockdown and restrictions imposed during the pandemic. The number of blood donations reduced significantly due to the lockdowns and the fear of getting infected, which in turn reduced the blood transfusion-related screenings. However, the number of blood donations has increased since lockdown restrictions have been relaxed. The American Red Cross also began testing all blood, platelet, and plasma donations for COVID-19 antibodies to provide the donor insights into whether they have been exposed to the coronavirus.

Therefore, even though blood donations and transfusion-related screenings might have taken a hit during the peak months of the pandemic, the overall impact of COVID-19 is expected to contribute positively toward the growth of the blood screening market.

Key Findings of the Blood Screening Market Study:

The Reagents & Kits Segment to Dominate the Market

By product, the reagents & kits segment is projected to command the largest share of the blood screening market in 2020. Reagents being a recurrent expense, are extensively used for immunoassays and molecular tests. Factors such as increasing blood donations and transfusion-related screenings and the increasing prevalence of infectious diseases are driving the growth of this segment. Moreover, due to the outbreak of COVID-19, there has been an increase in serological testing, which has also contributed to the growth of this segment.

The Nucleic Acid Amplification Segment to Dominate the Market

By technology, the nucleic acid amplification segment is projected to command the largest share of the blood screening market in 2020. The largest share is attributed to the superior benefits of the technology, such as high sensitivity and specificity for early detection. Moreover, the widespread adoption of this technology in blood banks, hospitals, and clinical laboratories also contributes to its largest share. Additionally, the high adoption of this technology in emerging markets and developing countries provides great opportunities for the growth of this segment. However, requirements such as skilled labor and high-cost initial infrastructure are expected to pose challenges for the growth of this segment.

The Blood Banks Segment to Dominate the Market

By End User, the blood banks segment is projected to command the largest share of the blood screening market. Laboratory screening of donated blood and blood products for infectious diseases is a key safety measure to protect patients and to prevent the spread of serious infectious diseases. Factors such as increasing blood donations and transfusion-related screenings, growing awareness about transfusion-transmitted infections, and the rising occurrence of infectious diseases are driving the growth of this segment.

North America: The Largest Regional Market

In 2020, North America is expected to dominate the blood screening market. North America’s largest share is primarily attributed to the increasing blood transfusion-related screenings, growing prevalence of infectious diseases, rising geriatric population, need for early disease diagnosis and monitoring, increasing healthcare expenditure, and the growing adoption of advanced blood screening technologies in the region.

Key Players

The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments by leading market players in the industry over the past four years (2017–2020). The key players profiled in the blood screening market are Abbott Laboratories (U.S.), OriGene Technologies, Inc. (U.S.), BioAim Scientific Inc. (Canada), bioMérieux, Inc. (France), Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immuno-Biological Laboratories Co., Ltd. (Japan), Biovision, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Boster Biological Technology (U.S.), Cusabio Technology LLC (U.S.), Danaher Corporation (U.S.), Demeditec Diagnostics GmbH (Germany), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.

Scope of the Report:

Blood Screening Market, by Product

  • Reagents & Kits
    • NAT Kits & Reagents
    • ELISA Kits & Reagents
    • Other Kits & Reagents
  • Instruments
  • Software & Services

Blood Screening Market, by Technology

  • Nucleic Acid Amplification
    • Transcription Mediated Amplification (TMA)
    • Real-time PCR
  • ELISA
    • Chemiluminescence Immunoassay (CLIA)
    • Fluorescence Immunoassay (FIA)
    • Colorimetric Immunoassay (CI)
  • Rapid Tests
  • Western Blotting
  • Next-generation Sequencing (NGS)

Blood Screening Market, by End User

  • Blood Banks
  • Hospitals
  • Clinical Laboratories

Blood Screening Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key Questions Answered in the Report:

  Request Sample

1. Introduction
      1.1. Market Definition
      1.2. Market Ecosystem
      1.3. Currency
      1.4. Key Stakeholders

2. Research Methodology
      2.1. Research Process
      2.2. Data Collection & Validation
              2.2.1. Secondary Research
              2.2.2. Primary Research
      2.3. Market Assessment
              2.3.1. Market Size Estimation
                         2.3.1.1. Bottom-up Approach
                         2.3.1.2. Top-down Approach
                         2.3.1.3. Growth forecast
              2.3.2. Market Share Analysis
      2.4. Assumptions for this Study
      2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
      4.1. Introduction
      4.2. Drivers
              4.2.1. Increasing Number of Blood Donations and Transfusion-related Screenings
              4.2.2. Growing Prevalence of Infectious Diseases and the Need for Early Diagnosis
              4.2.3. Increasing Government and Non-government Initiatives
      4.3. Restraints
              4.3.1. Lack of Legislation, Regulations, and Policies
              4.3.2. Development of Alternative Technologies
      4.4. Opportunities
              4.4.1. Emerging Markets in Developing and Underdeveloped Countries
              4.4.2. Adoption of New Technologies & Rapid Technological Advancements
      4.5. Challenges
              4.5.1. Increasing Competition
      4.6. COVID-19 Impact Assessment 

5. Global Blood Screening Market, by Product
      5.1. Introduction
      5.2. Reagents & Kits
              5.2.1. NAT Reagents & Kits
              5.2.2. ELISA Reagents & Kits
              5.2.3. Other Reagents & Kits
      5.3. Instruments
      5.4. Software & Services

6. Global Blood Screening Market, by Technology
      6.1. Introduction
      6.2. Nucleic Acid Amplification
              6.2.1. Transcription Mediated Amplification (TMA)
              6.2.2. Real-time PCR (RT-PCR)
      6.3. Enzyme-linked Immunosorbent Assay (ELISA)
              6.3.1. Chemiluminescent Immunoassay
              6.3.2. Fluorescence Immunoassays (FIA)
              6.3.3. Colorimetric Immunoassays (CI)
      6.4. Rapid Tests
      6.5. Western Blotting
      6.6. Next-generation Sequencing (NGS)

7. Global Blood Screening Market, by End User
      7.1. Introduction
      7.2. Blood Banks
      7.3. Hospitals
      7.4. Clinical Laboratories

8. Global Blood Screening Market, by Geography
      8.1. Introduction
      8.2. North America
              8.2.1. U.S.
              8.2.2. Canada
      8.3. Europe
              8.3.1. Germany
              8.3.2. France
              8.3.3. U.K.
              8.3.4. Italy
              8.3.5. Spain
              8.3.6. Rest of Europe (RoE)
      8.4. Asia-Pacific
              8.4.1. China
              8.4.2. Japan
              8.4.3. India
              8.4.4. Rest of Asia-Pacific (RoAPAC)
      8.5. Latin America
      8.6. Middle East & Africa

9. Competitive Landscape
      9.1. Introduction
      9.2. Key Growth Strategies
      9.3. Competitive Benchmarking
      9.4. Market Share Analysis (2019)
              9.4.1. Becton, Dickinson and Company
              9.4.2. Abbott Laboratories
              9.4.3. F. Hoffmann-La Roche Ltd

10. Company Profiles
        10.1. Abbott Laboratories
                  10.1.1. Business Overview
                  10.1.2. Financial Overview
                  10.1.3. Product Portfolio
                  10.1.4. Strategic Developments
                               10.1.4.1. New Product Launches & Approvals
                               10.1.4.2. Partnerships
        10.2. bioMerieux, Inc.
                  10.2.1. Business Overview
                  10.2.2. Financial Overview
                  10.2.3. Product Portfolio
                  10.2.4. Strategic Developments
                               10.2.4.1. Approvals
                               10.2.4.2. Acquisitions
        10.3. Bio-Rad Laboratories, Inc.
                  10.3.1. Business Overview
                  10.3.2. Financial Overview
                  10.3.3. Product Portfolio
                  10.3.4. Strategic Developments
                               10.3.4.1. New Product Launches & Approvals
        10.4. Grifols, S.A.
                  10.4.1. Business Overview
                  10.4.2. Financial Overview
                  10.4.3. Product Portfolio
                  10.4.4. Strategic Developments
                               10.4.4.1. Approvals
                               10.4.4.2. Acquisitions
                               10.4.4.3. Agreements
        10.5. Becton, Dickinson and Company
                  10.5.1. Business Overview
                  10.5.2. Financial Overview
                  10.5.3. Product Portfolio
                  10.5.4. Strategic Developments
                               10.5.4.1. New Product Launches
                               10.5.4.2. Agreements
        10.6. F. Hoffmann-La Roche Ltd.
                  10.6.1. Business Overview
                  10.6.2. Financial Overview
                  10.6.3. Product Portfolio
                  10.6.4. Strategic Developments
                               10.6.4.1. New Product Launches & Approvals
        10.7. Boster Biological Technology
                  10.7.1. Business Overview
                  10.7.2. Product Portfolio
                  10.7.3. Strategic Developments
                               10.7.3.1. Partnerships
        10.8. Cusabio Technology LLC
                  10.8.1. Business Overview
                  10.8.2. Product Portfolio
        10.9. Danaher Corporation
                  10.9.1. Business Overview
                  10.9.2. Financial Overview
                  10.9.3. Product Portfolio
                  10.9.4. Strategic Developments
                               10.9.4.1. New Product Launches & Approvals
                               10.9.4.2. Acquisitions
                               10.9.4.3. Collaborations
        10.10. Demeditec Diagnostics GmbH
                    10.10.1. Business Overview
                    10.10.2. Product Portfolio
                    10.10.3. Strategic Developments
                                  10.10.3.1. New Product Launches

11. Appendix
        11.1. Questionnaire
        11.2. Available Customization

List of Tables :-

Table 1 Global Blood Screening Market Drivers: Impact Analysis (2020–2027)
Table 2 Estimated Units of Donated Blood Collected Per Year
Table 3 List of Donor Blood Screening Tests
Table 4 Global Blood Screening Market Restraints: Impact Analysis (2020–2027)
Table 5 Percentage of Countries Lacking National Blood Policy per Region
Table 6 COVID-19 Confirmed Cases and Deaths Worldwide (as of 21st December 2020)
Table 7 Recent Serological Tests Launched for COVID-19
Table 8 Global Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 9 Global Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 10 Global Blood Screening Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 11 Recent Approvals for Nat Reagents & Kits
Table 12 Key Companies Offering Blood Screening Nat Reagents & Kits
Table 13 Global NAT Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 14 Recent Launches and Approvals for ELISA Reagents & Kits
Table 15 Key Companies Offering Blood Screening ELISA Reagents & Kits
Table 16 Global ELISA Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 17 Key Companies Offering Other Reagents & Kits
Table 18 Global Other Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 19 Recent Instrument Launches & Approvals
Table 20 Key Companies Offering Blood Screening Instruments
Table 21 Global Blood Screening Instruments Market Size, by Country/Region, 2018–2027 (USD Million)
Table 22 Key Companies Offering Blood Screening Software & Services
Table 23 Global Blood Screening Software & Services Market Size, by Country/Region, 2018–2027 (USD Million)
Table 24 Global Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 25 Global Nucleic Acid Amplification-based Blood Screening Market Size, by Type, 2018–2027 (USD Million)
Table 26 Global Nucleic Acid Amplification-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 27 Global TMA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 28 Key Companies Offering Real-time PCR-based Blood Screening Products
Table 29 Global Real-time PCR-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 30 Global ELISA-based Blood Screening Market Size, by Type, 2018–2027 (USD Million)
Table 31 Global ELISA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 32 Key Companies Offering CLIA-based Products
Table 33 Global CLIA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 34 Key Companies Offering FIA-based Products
Table 35 Global FIA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 36 Key Companies Offering CI-based Products
Table 37 Global CI-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 38 Key Companies Offering Rapid Test-based Products
Table 39 Global Rapid Test-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 40 Key Companies Offering Western Blotting-based Products
Table 41 Global Western Blotting-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 42 Global Next-generation Sequencing-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 43 Global Blood Screening Market Size, by End User, 2020–2027 (USD Million)
Table 44 Global Blood Screening Market Size for Blood Banks, by Country/Region, 2020–2027 (USD Million)
Table 45 Global Blood Screening Market Size for Hospitals, by Country/Region, 2020–2027 (USD Million)
Table 46 Global Blood Screening Market Size for Clinical Laboratories, by Country/Region, 2020–2027 (USD Million)
Table 47 Global Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 48 North America: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 49 North America: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 50 North America: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 51 North America: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 52 North America: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 53 North America: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 54 North America: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 55 Blood Screening Tests Recommended by Centers for Disease Control & Prevention
Table 56 U.S.: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 57 U.S.: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 58 U.S.: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 59 U.S.: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 60 U.S.: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 61 U.S.: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 62 Canada: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 63 Canada: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 64 Canada: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 65 Canada: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 66 Canada: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 67 Canada: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 68 Europe: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 69 Europe: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 70 Europe: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 71 Europe: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 72 Europe: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 73 Europe: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 74 Europe: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 75 Germany: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 76 Germany: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 77 Germany: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 78 Germany: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 79 Germany: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 80 Germany: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 81 France: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 82 France: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 83 France: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 84 France: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 85 France: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 86 France: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 87 U.K.: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 88 U.K.: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 89 U.K.: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 90 U.K.: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 91 U.K.: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 92 U.K.: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 93 Italy: Cancer Prevalence 2020
Table 94 Italy: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 95 Italy: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 96 Italy: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 97 Italy: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 98 Italy: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 99 Italy: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 100 Spain: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 101 Spain: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 102 Spain: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 103 Spain: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 104 Spain: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 105 Spain: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 106 RoE: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 107 RoE: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 108 RoE: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 109 RoE: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 110 RoE: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 111 RoE: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 112 Asia-Pacific: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 113 Asia-Pacific: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 114 Asia-Pacific: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 115 Asia-Pacific: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 116 Asia-Pacific: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 117 Asia-Pacific: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 118 Asia-Pacific: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 119 China: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 120 China: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 121 China: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 122 China: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 123 China: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 124 China: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 125 Japan: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 126 Japan: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 127 Japan: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 128 Japan: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 129 Japan: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 130 Japan: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 131 India: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 132 India: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 133 India: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 134 India: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 135 India: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 136 India: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 137 Rest of Asia-Pacific: Number of Infectious Disease Cases in Major Countries
Table 138 RoAPAC: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 13  RoAPAC: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 140 RoAPAC: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 141 RoAPAC: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 142 RoAPAC: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 143 RoAPAC: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 144 Latin America: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 145 Latin America: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 146 Latin America: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 147 Latin America: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 148 Latin America: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 149 Latin America: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 150 Middle East & Africa: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 151 Middle East & Africa: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 152 Middle East & Africa: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 153 Middle East & Africa: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 154 Middle East & Africa: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 155 Middle East & Africa: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 156 Recent Developments, by Company, 2017–2020

List of Figures :-

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Blood Screening Market Size, by Product, 2020 Vs. 2027 (USD Million)
Figure 8 Global Blood Screening Market Size, by Technology, 2020 Vs. 2027 (USD Million)
Figure 9 Blood Banks Segment Expected to Dominate the Global Blood Screening Market, by End User, (2020–2027)
Figure 10 Blood Screening Market, by Region
Figure 11 Market Dynamics
Figure 12 Global Blood Screening Market Size, by Product, 2020–2027 (USD Million)
Figure 13 Global Blood Screening Market Size, by Technology, 2020–2027 (USD Million)
Figure 14 Global Blood Screening Market Size, by End User, 2020–2027 (USD Million)
Figure 15 Global Blood Screening Market Size, by Geography, 2020–2027 (USD Million)
Figure 16 North America: Blood Screening Market Snapshot
Figure 17 Europe: Blood Screening Market Snapshot
Figure 18 Asia-Pacific: Blood Screening Market Snapshot
Figure 19 Middle East & Africa: Road Fatalities per 100,000 Population per Year
Figure 20 Key Growth Strategies Adopted by Leading Players, 2017–2020
Figure 21 Blood Screening: Competitive Benchmarking
Figure 22 Blood Screening: Competitive Benchmarking by Geography
Figure 23 Market Share Analysis: Blood Screening Industry, 2019
Figure 24 Abbott Laboratories: Financial Overview (2019)
Figure 25 bioMerieux, Inc.: Financial Overview (2019)
Figure 26 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
Figure 27 Grifols, S.A.: Financial Overview (2019)
Figure 28 Becton, Dickinson and Company: Financial Overview (2019)
Figure 29 F. Hoffmann-La Roche Ltd: Financial Overview (2019)
Figure 30 Danaher Corporation: Financial Overview (2019)

  Request Sample

1. Introduction
      1.1. Market Definition
      1.2. Market Ecosystem
      1.3. Currency
      1.4. Key Stakeholders

2. Research Methodology
      2.1. Research Process
      2.2. Data Collection & Validation
              2.2.1. Secondary Research
              2.2.2. Primary Research
      2.3. Market Assessment
              2.3.1. Market Size Estimation
                         2.3.1.1. Bottom-up Approach
                         2.3.1.2. Top-down Approach
                         2.3.1.3. Growth forecast
              2.3.2. Market Share Analysis
      2.4. Assumptions for this Study
      2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
      4.1. Introduction
      4.2. Drivers
              4.2.1. Increasing Number of Blood Donations and Transfusion-related Screenings
              4.2.2. Growing Prevalence of Infectious Diseases and the Need for Early Diagnosis
              4.2.3. Increasing Government and Non-government Initiatives
      4.3. Restraints
              4.3.1. Lack of Legislation, Regulations, and Policies
              4.3.2. Development of Alternative Technologies
      4.4. Opportunities
              4.4.1. Emerging Markets in Developing and Underdeveloped Countries
              4.4.2. Adoption of New Technologies & Rapid Technological Advancements
      4.5. Challenges
              4.5.1. Increasing Competition
      4.6. COVID-19 Impact Assessment 

5. Global Blood Screening Market, by Product
      5.1. Introduction
      5.2. Reagents & Kits
              5.2.1. NAT Reagents & Kits
              5.2.2. ELISA Reagents & Kits
              5.2.3. Other Reagents & Kits
      5.3. Instruments
      5.4. Software & Services

6. Global Blood Screening Market, by Technology
      6.1. Introduction
      6.2. Nucleic Acid Amplification
              6.2.1. Transcription Mediated Amplification (TMA)
              6.2.2. Real-time PCR (RT-PCR)
      6.3. Enzyme-linked Immunosorbent Assay (ELISA)
              6.3.1. Chemiluminescent Immunoassay
              6.3.2. Fluorescence Immunoassays (FIA)
              6.3.3. Colorimetric Immunoassays (CI)
      6.4. Rapid Tests
      6.5. Western Blotting
      6.6. Next-generation Sequencing (NGS)

7. Global Blood Screening Market, by End User
      7.1. Introduction
      7.2. Blood Banks
      7.3. Hospitals
      7.4. Clinical Laboratories

8. Global Blood Screening Market, by Geography
      8.1. Introduction
      8.2. North America
              8.2.1. U.S.
              8.2.2. Canada
      8.3. Europe
              8.3.1. Germany
              8.3.2. France
              8.3.3. U.K.
              8.3.4. Italy
              8.3.5. Spain
              8.3.6. Rest of Europe (RoE)
      8.4. Asia-Pacific
              8.4.1. China
              8.4.2. Japan
              8.4.3. India
              8.4.4. Rest of Asia-Pacific (RoAPAC)
      8.5. Latin America
      8.6. Middle East & Africa

9. Competitive Landscape
      9.1. Introduction
      9.2. Key Growth Strategies
      9.3. Competitive Benchmarking
      9.4. Market Share Analysis (2019)
              9.4.1. Becton, Dickinson and Company
              9.4.2. Abbott Laboratories
              9.4.3. F. Hoffmann-La Roche Ltd

10. Company Profiles
        10.1. Abbott Laboratories
                  10.1.1. Business Overview
                  10.1.2. Financial Overview
                  10.1.3. Product Portfolio
                  10.1.4. Strategic Developments
                               10.1.4.1. New Product Launches & Approvals
                               10.1.4.2. Partnerships
        10.2. bioMerieux, Inc.
                  10.2.1. Business Overview
                  10.2.2. Financial Overview
                  10.2.3. Product Portfolio
                  10.2.4. Strategic Developments
                               10.2.4.1. Approvals
                               10.2.4.2. Acquisitions
        10.3. Bio-Rad Laboratories, Inc.
                  10.3.1. Business Overview
                  10.3.2. Financial Overview
                  10.3.3. Product Portfolio
                  10.3.4. Strategic Developments
                               10.3.4.1. New Product Launches & Approvals
        10.4. Grifols, S.A.
                  10.4.1. Business Overview
                  10.4.2. Financial Overview
                  10.4.3. Product Portfolio
                  10.4.4. Strategic Developments
                               10.4.4.1. Approvals
                               10.4.4.2. Acquisitions
                               10.4.4.3. Agreements
        10.5. Becton, Dickinson and Company
                  10.5.1. Business Overview
                  10.5.2. Financial Overview
                  10.5.3. Product Portfolio
                  10.5.4. Strategic Developments
                               10.5.4.1. New Product Launches
                               10.5.4.2. Agreements
        10.6. F. Hoffmann-La Roche Ltd.
                  10.6.1. Business Overview
                  10.6.2. Financial Overview
                  10.6.3. Product Portfolio
                  10.6.4. Strategic Developments
                               10.6.4.1. New Product Launches & Approvals
        10.7. Boster Biological Technology
                  10.7.1. Business Overview
                  10.7.2. Product Portfolio
                  10.7.3. Strategic Developments
                               10.7.3.1. Partnerships
        10.8. Cusabio Technology LLC
                  10.8.1. Business Overview
                  10.8.2. Product Portfolio
        10.9. Danaher Corporation
                  10.9.1. Business Overview
                  10.9.2. Financial Overview
                  10.9.3. Product Portfolio
                  10.9.4. Strategic Developments
                               10.9.4.1. New Product Launches & Approvals
                               10.9.4.2. Acquisitions
                               10.9.4.3. Collaborations
        10.10. Demeditec Diagnostics GmbH
                    10.10.1. Business Overview
                    10.10.2. Product Portfolio
                    10.10.3. Strategic Developments
                                  10.10.3.1. New Product Launches

11. Appendix
        11.1. Questionnaire
        11.2. Available Customization

List of Tables :-

Table 1 Global Blood Screening Market Drivers: Impact Analysis (2020–2027)
Table 2 Estimated Units of Donated Blood Collected Per Year
Table 3 List of Donor Blood Screening Tests
Table 4 Global Blood Screening Market Restraints: Impact Analysis (2020–2027)
Table 5 Percentage of Countries Lacking National Blood Policy per Region
Table 6 COVID-19 Confirmed Cases and Deaths Worldwide (as of 21st December 2020)
Table 7 Recent Serological Tests Launched for COVID-19
Table 8 Global Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 9 Global Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 10 Global Blood Screening Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 11 Recent Approvals for Nat Reagents & Kits
Table 12 Key Companies Offering Blood Screening Nat Reagents & Kits
Table 13 Global NAT Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 14 Recent Launches and Approvals for ELISA Reagents & Kits
Table 15 Key Companies Offering Blood Screening ELISA Reagents & Kits
Table 16 Global ELISA Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 17 Key Companies Offering Other Reagents & Kits
Table 18 Global Other Reagents & Kits Market Size, by Country/Region, 2018–2027 (USD Million)
Table 19 Recent Instrument Launches & Approvals
Table 20 Key Companies Offering Blood Screening Instruments
Table 21 Global Blood Screening Instruments Market Size, by Country/Region, 2018–2027 (USD Million)
Table 22 Key Companies Offering Blood Screening Software & Services
Table 23 Global Blood Screening Software & Services Market Size, by Country/Region, 2018–2027 (USD Million)
Table 24 Global Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 25 Global Nucleic Acid Amplification-based Blood Screening Market Size, by Type, 2018–2027 (USD Million)
Table 26 Global Nucleic Acid Amplification-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 27 Global TMA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 28 Key Companies Offering Real-time PCR-based Blood Screening Products
Table 29 Global Real-time PCR-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 30 Global ELISA-based Blood Screening Market Size, by Type, 2018–2027 (USD Million)
Table 31 Global ELISA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 32 Key Companies Offering CLIA-based Products
Table 33 Global CLIA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 34 Key Companies Offering FIA-based Products
Table 35 Global FIA-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 36 Key Companies Offering CI-based Products
Table 37 Global CI-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 38 Key Companies Offering Rapid Test-based Products
Table 39 Global Rapid Test-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 40 Key Companies Offering Western Blotting-based Products
Table 41 Global Western Blotting-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 42 Global Next-generation Sequencing-based Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 43 Global Blood Screening Market Size, by End User, 2020–2027 (USD Million)
Table 44 Global Blood Screening Market Size for Blood Banks, by Country/Region, 2020–2027 (USD Million)
Table 45 Global Blood Screening Market Size for Hospitals, by Country/Region, 2020–2027 (USD Million)
Table 46 Global Blood Screening Market Size for Clinical Laboratories, by Country/Region, 2020–2027 (USD Million)
Table 47 Global Blood Screening Market Size, by Country/Region, 2018–2027 (USD Million)
Table 48 North America: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 49 North America: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 50 North America: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 51 North America: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 52 North America: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 53 North America: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 54 North America: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 55 Blood Screening Tests Recommended by Centers for Disease Control & Prevention
Table 56 U.S.: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 57 U.S.: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 58 U.S.: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 59 U.S.: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 60 U.S.: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 61 U.S.: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 62 Canada: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 63 Canada: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 64 Canada: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 65 Canada: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 66 Canada: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 67 Canada: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 68 Europe: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 69 Europe: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 70 Europe: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 71 Europe: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 72 Europe: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 73 Europe: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 74 Europe: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 75 Germany: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 76 Germany: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 77 Germany: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 78 Germany: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 79 Germany: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 80 Germany: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 81 France: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 82 France: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 83 France: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 84 France: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 85 France: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 86 France: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 87 U.K.: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 88 U.K.: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 89 U.K.: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 90 U.K.: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 91 U.K.: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 92 U.K.: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 93 Italy: Cancer Prevalence 2020
Table 94 Italy: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 95 Italy: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 96 Italy: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 97 Italy: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 98 Italy: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 99 Italy: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 100 Spain: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 101 Spain: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 102 Spain: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 103 Spain: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 104 Spain: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 105 Spain: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 106 RoE: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 107 RoE: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 108 RoE: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 109 RoE: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 110 RoE: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 111 RoE: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 112 Asia-Pacific: Blood Screening Market Size, by Country, 2018–2027 (USD Million)
Table 113 Asia-Pacific: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 114 Asia-Pacific: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 115 Asia-Pacific: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 116 Asia-Pacific: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 117 Asia-Pacific: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 118 Asia-Pacific: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 119 China: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 120 China: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 121 China: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 122 China: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 123 China: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 124 China: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 125 Japan: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 126 Japan: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 127 Japan: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 128 Japan: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 129 Japan: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 130 Japan: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 131 India: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 132 India: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 133 India: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 134 India: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 135 India: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 136 India: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 137 Rest of Asia-Pacific: Number of Infectious Disease Cases in Major Countries
Table 138 RoAPAC: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 13  RoAPAC: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 140 RoAPAC: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 141 RoAPAC: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 142 RoAPAC: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 143 RoAPAC: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 144 Latin America: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 145 Latin America: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 146 Latin America: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 147 Latin America: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 148 Latin America: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 149 Latin America: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 150 Middle East & Africa: Blood Screening Market Size, by Product, 2018–2027 (USD Million)
Table 151 Middle East & Africa: Blood Screening Reagents & Kits Market Size, by Type, 2018–2027 (USD Million)
Table 152 Middle East & Africa: Blood Screening Market Size, by Technology, 2018–2027 (USD Million)
Table 153 Middle East & Africa: Blood Screening Nucleic Acid Amplification Market Size, by Type, 2018–2027 (USD Million)
Table 154 Middle East & Africa: Blood Screening ELISA Market Size, by Type, 2018–2027 (USD Million)
Table 155 Middle East & Africa: Blood Screening Market Size, by End User, 2018–2027 (USD Million)
Table 156 Recent Developments, by Company, 2017–2020

List of Figures :-

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Blood Screening Market Size, by Product, 2020 Vs. 2027 (USD Million)
Figure 8 Global Blood Screening Market Size, by Technology, 2020 Vs. 2027 (USD Million)
Figure 9 Blood Banks Segment Expected to Dominate the Global Blood Screening Market, by End User, (2020–2027)
Figure 10 Blood Screening Market, by Region
Figure 11 Market Dynamics
Figure 12 Global Blood Screening Market Size, by Product, 2020–2027 (USD Million)
Figure 13 Global Blood Screening Market Size, by Technology, 2020–2027 (USD Million)
Figure 14 Global Blood Screening Market Size, by End User, 2020–2027 (USD Million)
Figure 15 Global Blood Screening Market Size, by Geography, 2020–2027 (USD Million)
Figure 16 North America: Blood Screening Market Snapshot
Figure 17 Europe: Blood Screening Market Snapshot
Figure 18 Asia-Pacific: Blood Screening Market Snapshot
Figure 19 Middle East & Africa: Road Fatalities per 100,000 Population per Year
Figure 20 Key Growth Strategies Adopted by Leading Players, 2017–2020
Figure 21 Blood Screening: Competitive Benchmarking
Figure 22 Blood Screening: Competitive Benchmarking by Geography
Figure 23 Market Share Analysis: Blood Screening Industry, 2019
Figure 24 Abbott Laboratories: Financial Overview (2019)
Figure 25 bioMerieux, Inc.: Financial Overview (2019)
Figure 26 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
Figure 27 Grifols, S.A.: Financial Overview (2019)
Figure 28 Becton, Dickinson and Company: Financial Overview (2019)
Figure 29 F. Hoffmann-La Roche Ltd: Financial Overview (2019)
Figure 30 Danaher Corporation: Financial Overview (2019)

  Request Sample
Related Research